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Background-—Early postoperative atrial ﬁbrillation (EPoAF) is associated with thromboembolic events, prolonged hospitalization,
and development of late PoAF (LPoAF). It is, however, unknown if EPoAF can be predicted by intraoperative AF inducibility. The
aims of this study are therefore to explore (1) the value of intraoperative inducibility of AF for development of both EPoAF and
LPoAF and (2) the predictive value of de novo EPoAF for recurrence of LPoAF.
Methods and Results-—Patients (N=496, 75% male) undergoing cardiothoracic surgery for coronary and/or valvular heart disease
were included. AF induction was attempted by atrial pacing, before extracorporeal circulation. All patients were on continuous
rhythm monitoring until discharge to detect EPoAF. During a follow-up period of 2 years, LPoAF was detected by ECGs and Holter
recordings. Sustained AF was inducible in 56% of patients. There was no difference in patients with or without AF before surgery
(P=0.159), or between different types of surgery (P=0.687). In patients without a history of AF, incidence of EPoAF and LPoAF was
37% and 2%, respectively. EPoAF recurred in 58% patients with preoperative AF, 53% developed LPoAF. There were no correlations
between intraoperative inducibility and EPoAF or LPoAF (P>0.05). EPoAF was not correlated with LPoAF in patients without a
history of AF (P=0.116), in contrast to patients with AF before surgery (P<0.001).
Conclusions-—Intraoperative AF inducibility does not predict development of either EPoAF or LPoAF. In patients with AF before
surgery, EPoAF is correlated with LPoAF recurrences. This correlation is absent in patients without AF before surgery. ( J Am Heart
Assoc. 2018;7:e007879. DOI: 10.1161/JAHA.117.007879.)
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O ver the past decades, cardiac surgery has become anestablished treatment modality for various cardiovascu-
lar diseases. However, despite improved surgical techniques
and health care over the years, atrial ﬁbrillation (AF) is still
frequently observed in the early postoperative period.
Reported incidences of early postoperative AF (EPoAF) range
from 10% to 65%.1–4 EPoAF is associated with thromboem-
bolic complications and prolonged hospitalization.3,5,6 A
previous study demonstrated, although in a small population
(N=50) with coronary artery disease, that intraoperative
inducibility of AF could be a predictor for development of
EPoAF.7 However, this was never validated in a larger
population with a variety of cardiovascular diseases.
In addition, EPoAF is known to increase the risk of late
postoperative AF (LPoAF),6,8,9 yet the predictive value of
intraoperative inducibility was never investigated. The latest
European guidelines advise to consider long-term oral antico-
agulants in cases of EPoAF as prevention for thromboembolic
complications (Class IIa).10 However, they also concluded that
additional research is mandatory to investigate the predictive
value of short-lasting (<24 hours) EPoAF episodes for
development of LPoAF. Hence, there is a need to identify
patients at risk for EPoAF and, subsequently, to determine
whether these patients are also at risk for LPoAF.
The aims of this study are therefore to explore (1) the value
of intraoperative inducibility of AF for development of both
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EPoAF and LPoAF and (2) the predictive value of de novo
EPoAF episodes of any duration >30 seconds for recurrence
of LPoAF.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Study Population
The study population consisted of 496 adult patients,
scheduled for elective cardiac surgery, including isolated
coronary artery bypass grafting (CABG), isolated valvular heart
surgery (VHS), a combination of VHS and CABG (VHS+CABG)
or correction of a congenital heart defect (Figure 1). Patients
with an atrial pacing device, previous ablation of atrial
arrhythmias, or severe renal failure or patients requiring
mechanical or inotropic support before the surgical procedure
were not eligible for inclusion. Surgical pulmonary vein
isolation was performed in a selection of patients with a
history of AF. Classiﬁcation of AF was performed according to
the latest guidelines.10
Patients were included in either the QUASAR11 (Quest for
the Arrhythmogenic Substrate of Atrial Fibrillation) or
HALT&REVERSE12 (HSF1 activators lower cardiomyocyte
damage; towards a novel approach to reverse AF) project,
which were both approved by the institutional medical ethical
committee (MEC2010-054 and MEC2014-393). All patients
provided written informed consent before inclusion. Clinical
characteristics were obtained from electronic patient ﬁles.
Figure 1. Flowchart patient inclusion. CABG indicates coro-
nary artery bypass grafting; CHD, congenital heart disease;
LPoAF, late postoperative atrial ﬁbrillation; VHD, valvular heart
disease.
Clinical Perspective
What Is New?
• Intraoperative atrial ﬁbrillation inducibility does not predict
development of early postoperative atrial ﬁbrillation.
• In patients without a history of atrial ﬁbrillation, early
postoperative atrial ﬁbrillation is not correlated with late
recurrences of atrial ﬁbrillation; hence, a more conservative
approach with regard to initiation of oral anticoagulants may
be justiﬁed in this subpopulation.
What Are the Clinical Implications?
• In patients with a history of atrial ﬁbrillation, early postop-
erative atrial ﬁbrillation is correlated with late recurrences of
atrial ﬁbrillation; thus, these patients should be monitored
closely for recurrences, before discontinuation of oral
anticoagulants can even be considered.
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Intraoperative Induction of AF by Electrical
Stimulation
QUASAR and HALT&REVERSE are high-resolution epicardial
mapping studies, designed to investigate the arrhythmogenic
substrate underlying AF. For this purpose, mapping is
performed during either spontaneous or electrically induced
AF. AF induction is attempted in every patient before
commencement of extracorporeal circulation by ﬁxed-rate
pacing at the right atrial appendage, delivered by a temporary
pacemaker wire (pulse width: 2 ms, output 10 mA). Pacing
started at a rate of 200 bpm, and if AF was not induced after 2
attempts, the rate was gradually increased by steps of 50
bpm. If AF was not induced at a pacing rate of 400 bpm or
loss of capture occurred, attempts were terminated and AF
was considered noninducible.13 Attempts for inducibility of
AF were categorized as (1) noninducibility; (2) nonsustained
AF (self-terminating during mapping procedure); (3) nonsus-
tained atrial ﬂutter; (4) sustained AF (not self-terminating
during mapping procedure, 4 minutes); and (5) sustained
atrial ﬂutter.
Early Postoperative AF
Postoperative cardiac rhythms were continuously recorded
during the ﬁrst 4 to 5 days. Telemetry recordings, ECGs, and
patient records were all manually evaluated for the presence
of AF episodes. EPoAF was deﬁned as irregular RR intervals in
the absence of distinct P waves, with a duration of at least 30
seconds occurring within 14 days after the surgery.
Late Postoperative AF
For this subanalysis, we included only those patients who
completed a 2-year follow-up period by March 2017 or
developed AF within this period. LPoAF was detected on
either ECGs or 24-hour Holter recordings. If applicable,
additional rhythm registrations obtained during the follow-up
period were requested from the referring hospital.
Statistical Analysis
All data were tested for normality. Continuous, normally
distributed data are expressed as meanSD and skewed data
as median (P25–P75). Student t tests were used to compare
normally distributed continuous clinical parameters. Non–
normally distributed clinical parameters were compared by
nonparametric tests including Mann-Whitney U-test. Fisher
exact or v2 tests were applied for categorical variables. The
correlation among EPoAF, LPoAF, AF induction, and clinical
characteristics was examined using Pearson or Spearman
tests where applicable. A P value of <0.05 was considered
statistically relevant. Statistical analyses were performed
using IBM SPSS Statistics 24 (IBM Corporation, Armonk, NY).
Results
Study Population
The study population consisted of 496 patients (age 6711
years, 373 [75%] male). Baseline characteristics are summa-
rized in Table 1. The majority of patients (N=273, 55%)
underwent CABG surgery, whereas VHS, or VHS+CABG was
performed in 122 (25%) and 82 (16%) patients, respectively.
The remaining 19 (4%) patients underwent ﬁrst-time surgical
correction of a congenital heart defect including mainly
patients with either atrial or ventricular septal defects.
A history of AF was present in 125 (25%) patients and was
either paroxysmal (N=54, 43.2%), persistent (N=47, 37.6%),
long-standing persistent (N=22, 17.6%), or permanent (N=2,
1.6%). Eighty (64%) of these patients underwent concomitant
surgical pulmonary vein isolation.
Intraoperative Inducibility of AF
At the start of the mapping procedure, spontaneous AF was
present in 77 (15.5%) patients with a history of AF. In addition,
7 (1.4%) patients without a history of AF converted sponta-
neously to AF during surgery, before mapping. Pacing was not
performed due to patient-related or technical issues in
another 11 (2.2%) patients.
AF induction was attempted in all 401 remaining patients.
As depicted in Figure 2A, sustained AF was successfully
induced in 56% of these patients, whereas in 10% AF was
nonsustained. Either sustained atrial ﬂutter or nonsustained
atrial ﬂutter was induced in 6% and 7%, respectively. In 21% of
patients, arrhythmias were not inducible despite adequate
pacing attempts.
Figure 2B shows AF inducibility for patients without
(N=357) and with preoperative (N=44) AF separately. Induc-
tion of sustained AF was equally successful in patients with
preoperative AF (73%) and patients without (54%, P=0.159).
Intraoperative inducibility per type of surgery is indicated in
Figure 2C. There was no difference in AF inducibility between
the various groups, P=0.687.
Early Postoperative Atrial Fibrillation
Overall, EPoAF developed in 211 (43%) patients, including 138
(37%) patients without and 73 (58%) patients with preoperative
AF (P<0.001). Clinical characteristics of patients with and
without EPoAF are depicted in Table 2. Most initial EPoAF
episodes occurred at Day 3 (N=76, 36%) andDay 4 (N=53, 25%),
as opposed to Day 1 (N=17, 8%), Day 2 (N=23, 11%), Day 5
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(N=25, 12%), Day 6 (N=9, 4%), Day 7 (N=5, 2%), Day 8 (N=2, 1%),
and Day 11 (N=1, 1%). Figure 3 shows the cumulative onset of
EPoAF per postoperative day, for patients with (red bars) and
without (green bars) preoperative AF separately. EPoAF devel-
oped earlier (P<0.001). in patients with AF before surgery (Day
32) before surgery, than in patients without (Day 41).
In the subpopulation of 80 patients in whom surgical
pulmonary vein isolation was performed, EPoAF developed in
44% (N=35), compared with the recurrence of EPoAF in 84%
(N=38) of the patients in whom ablation was not performed
(P<0.001).
EPoAF terminated spontaneously in only 6 patients.
Patients received Class II (N=113), Class III (N=68), and/or
digoxin (N=45) as treatment for EPoAF. In 33 patients, EPoAF
Table 1. Baseline Characteristics
Total study
population No AF AF P value*
Population, N (%) 496 (100) 371 (75) 125 (25)
Group, N (%) <0.001
CABG 273 (55) 246 (66) 27 (22)
VHS 122 (25) 58 (16) 64 (51)
VHS/CABG 82 (16) 56 (15) 26 (21)
CHD 19 (4) 11 (3) 8 (6)
Age (years),
meanSD
6711 6511 719 <0.001
Male sex, N (%) 373 (75) 289 (78) 84 (67) 0.017
Hypertension, N (%) 276 (56) 206 (56) 70 (56) 0.926
Diabetes mellitus, N (%) 129 (26) 102 (27) 27 (22) 0.194
Hyperlipidemia,
N (%)
162 (33) 136 (37) 26 (21) 0.001
BMI (kg/m2),
meanSD
27.74.3 27.84.2 27.74.5 0.935
Antiarrhythmic
drugs,†
N (%)
367 (75) 271 (73) 96 (77) 0.408
Class I 2 (0.4) 2 (1) 0 (0) 0.399
Class II 367 (66) 254 (68) 75 (60) <0.001
Class III 27 (5) 5 (1) 22 (18) <0.001
Class IV 17 (3) 13 (4) 4 (3) 0.801
Left ventricular
function,
N (%)
0.059
Normal 364 (73) 282 (76) 82 (66) 0.023
Mild impairment 96 (19) 68 (18) 28 (22) 0.319
Moderate
impairment
34 (7) 20 (51) 14 (11) 0.026
Severe
impairment
2 (1) 1 (1) 1 (1) 0.418
Left atrial dilatation,‡
N (%)
132 (27) 66 (18) 66 (53) <0.001
AF type before CS,
N (%)
Paroxysmal AF 54 (43.2)
Persistent AF 47 (37.6)
Long-standing
persistent AF
22 (17.6)
Permanent AF 2 (1.6)
Surgical ablation 80 (64)
AF indicates atrial ﬁbrillation; BMI, body mass index; CABG, coronary artery bypass
grafting; CHD, congenital heart disease; CS, cardiac surgery; and VHS, heart valve
surgery.
*Comparing No AF and AF.
†Patients could use more than one type of AAD; therefore, the sum of all classes is not
100%.
‡Dimension >45 mm.
Figure 2. Intraoperative inducibility. Results of intraoperative
inducibility of various atrial tachyarrhythmias for the total study
population (A), for patients without or with AF before surgery (B)
and per type of cardiac surgery (C). AF indicates atrial ﬁbrillation;
AFL, atrial ﬂutter; CABG, coronary artery bypass grafting; CHD,
congenital heart disease; VHS, heart valve surgery.
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was treated by a combination of electrical cardioversion and
antiarrhythmic drugs.
Atdischargetothecenterof referralafter5(5–7)days,AFwas
present in 55 (11%) patients, including 14 (4%) patients without
preoperative AF and 41 (34%) patients with preoperative AF,
despite failed attempts to restore sinus rhythm in 75% (N=42).
Relation With Intraoperative Inducibility
The upper panel of Figure 4 indicates the proportion of
patients (N=357) that developed de novo EPoAF, for each
type of induced arrhythmia separately. There was no
correlation between the type of intraoperatively induced
arrhythmia and development of EPoAF (P>0.05). Similar
results were obtained for patients with preoperative AF
(N=44) who developed EPoAF recurrences, as indicated in the
lower panel of Figure 4 (P>0.05).
Late Postoperative AF
A total of 307 (62%) patients completed the 2-year follow-up
period, and/or reached the study end point (LPoAF). Forty-
four patients (14%) developed LPoAF during follow-up,
including only 4 (2%) patients without preoperative AF. AF
Table 2. Clinical Charateristics of Patients With and Without EPoAF
No AF AF
No EPoAF
(N=233)
EPoAF
(N=138) P Value
No EPoAF
(N=52) EPoAF (N=73) P value
Group, N (%) 0.006 0.951
CABG 160 (69) 86 (62) 10 (19) 17 (23)
VHS 38 (16) 20 (15) 27 (52) 37 (51)
VHS/CABG 25 (11) 31 (22) 12 (23) 14 (19)
CHD 10 (4) 1 (<1) 3 (6) 5 (7)
Age (years), meanSD 6312 698 <0.001 6810 727 0.014
Sex (male, %) 182 (78) 107 (78) 0.897 33 (63) 47 (64) 0.427
Hypertension, N (%) 128 (55) 78 (57) 0.766 28 (54) 42 (58) 0.682
Diabetes mellitus, N (%) 65 (28) 37 (27) 0.821 7 (13) 20 (28) 0.062
Hyperlipidemia, N (%) 87 (37) 49 (36) 0.723 11 (21) 15 (21) 0.934
BMI (kg/m2), meanSD 284 274 0.554 274 285 0.107
Antiarrhythmic drugs, N (%) 0.081 0.978
Class I 1 (<1) 1 (<1) 0 0
Class II 153 (66) 101 (73) 30 (58) 45 (62)
Class III 4 (2) 1 (<1) 11 (21) 11 (15)
Class IV 8 (3) 5 (4) 2 (4) 2 (3)
Left ventricular function, N (%) 0.180 0.148
Normal 185 (79) 97 (70) 38 (73) 44 (60)
Mild impairment 36 (15) 32 (23) 7 (13) 21 (29)
Moderate impairment 11 (5) 9 (7) 6 (12) 8 (11)
Severe impairment 1 (<1) 0 1 (2) 0
Left atrial dilatation, N (%) 40 (17) 26 (19) 0.684 21 (40) 45 (62) 0.019
AF type before CS, N (%) 0.116
Paroxysmal AF 26 (50) 28 (38)
Persistent AF 15 (29) 32 (44)
Long-standing Persistent AF 11 (21) 10 (14)
Permanent AF 0 3 (4)
Surgical ablation, N (%) 45 (87) 35 (48) <0.001
AF indicates atrial ﬁbrillation; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, congenital heart disease; CS, cardiac surgery; EPoAF, early postoperative atrial
ﬁbrillation; and VHS, valvular heart surgery.
DOI: 10.1161/JAHA.117.007879 Journal of the American Heart Association 5
Inducibility of AF Does Not Predict PoAF Lanters et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on M
arch 22, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
recurred in 40 (53%) patients with preoperative AF (P<0.001).
As expected, the incidence of LPoAF recurrences was lower in
patients who underwent ablation than in patients in whom
ablation was not performed: 25% versus 44%, P=0.021.
Table 3 shows additional clinical characteristics of patients
with and without LPoAF.
Overall time to LPoAF diagnosis was 6 (3–6) months and
was similar in patients with (N=40, 6 [3–6]) and patients
without (N=4, 8 [3–21]) preoperative AF (P=0.708).
Relation Between Late Postoperative AF and
Intraoperative Inducibility
In 3 (75%) patients with de novo LPoAF, intraoperative induction
resulted in sustained AF, the fourth patient had sustained atrial
ﬂutter. In patients with AF before surgery, 2 patients with LPoAF
were noninducible during surgery, 2 patients had nonsustained
AF, 8 patients had sustained AF, and 1 had sustained atrial
ﬂutter. However, in the majority of patients (N=27, 35%), AF
was spontaneously present at the start of the procedure. As a
consequence, there was no correlation between type of
arrhythmia induced and development of LPoAF for either
patients without (P=0.163) or with (P=0.211) AF before surgery.
Relation Between Early Postoperative and Late
Postoperative AF
Four patients without AF before surgery developed LPoAF,
including 1 patient without and 3 patients with EPoAF.
Consequently, there was no correlation between EPoAF and
LPoAF in this subgroup (P=0.116). LPoAF recurrences in the
subgroup with AF before surgery was observed in 6 patients
without and 34 patients with EPoAF episodes, resulting in a
signiﬁcant correlation between EPoAF and LPoAF: q=0.370
and P<0.001. Day of EPoAF onset did not correlate with
LPoAF development (P=0.390).
Discussion
Key Findings
Intraoperative AF is inducible in the vast majority of patients.
However, it is not correlated with development of EPoAF or
LPoAF. In patients without AF before surgery, the incidence of
LPoAF is very low and not related to the presence of EPoAF.
Clinical patient characteristics did not inﬂuence intraoperative
AF inducibility or development of either EPoAF or LPoAF.
Relation Between Inducibility and Early
Postoperative Atrial Fibrillation
The predictive value of AF inducibility for development of
EPoAF after cardiothoracic surgery has so far solely been
Figure 4. Relation between intraoperative inducibility and early
postoperative AF. Proportion of patients who develop EPoAF
(dashed) per type of arrhythmia induced, for patients without
(upper panel) and with (lower panel) AF before surgery. AF
indicates atrial ﬁbrillation; EPoAF, early postoperative atrial
ﬁbrillation; nsAF, non-sustained atrial ﬁbrillation; nsAFL, non-
sustained atrial ﬂutter; sAFL, sustained atrial ﬂutter.
Figure 3. Early postoperativeAF.CumulativeproportionofEPoAF
onset per postoperative day for patientswithout (green bars) or with
(red bars) AF before surgery. AF indicates atrial ﬁbrillation; EPoAF,
early postoperative atrial ﬁbrillation.
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investigated by Lowe et al.7 AF was induced in 72% of 50
patients without a history of AF undergoing CABG, slightly
more than in our population. They reported a sensitivity and
speciﬁcity of AF inducibility for predicting EPoAF of 94% and
41%, respectively.
In the present study, AF was inducible in the majority of
patients, and the incidence of de novo EPoAF was 37% (overall
EPoAF: 43%), which is comparable to incidences reported by
other investigators.2,6,8 However, a correlation between
inducibility of AF and development of EPoAF was absent.
Not only did we include a larger study population, but we also
tested our hypothesis in patients with various underlying heart
diseases. Within all these subgroups, these correlations were
lacking. In the study by Lowe et al, all antiarrhythmic drugs
were discontinued peri- and postoperatively, whereas in our
study all preoperatively prescribed drugs were continued. As a
result, AF inducibility is less likely to occur in our cohort.
Although the exact mechanisms of EPoAF are not fully
understood, it is generally accepted that it is highly multifac-
torial in nature.14 Factors promoting development of EPoAF
following cardiothoracic surgery include, for example, inﬂam-
matory response, sympathetic activation, and oxidative
stress. In addition, EPoAF is not solely initiated by the
presence of these triggers, but also depends on the presence
and extensiveness of an arrhythmogenic substrate.13,15 Atrial
alterations on structural, electrical, and contractile levels
Table 3. Clinical Charateristics of Patients With and Without LPoAF
No AF AF
No LPoAF (N=367) LPoAF (N=4) P Value No LPoAF (N=85) LPoAF (N=40) P value
Group, N (%) 0.010 0.498
CABG 245 (67) 1 (25) 19 (22) 8 (20)
VHS 58 (16) 0 42 (49) 22 (55)
VHS/CABG 53 (14) 3 (75) 20 (24) 6 (15)
CHD 11 (3) 0 4 (5) 4 (10)
Age (years), meanSD 6511 699 0.486 709 718 0.613
Sex (male, %) 285 (78) 4 (100) 0.284 54 (64) 30 (75) 0.203
Hypertension, N (%) 205 (56) 1 (25) 0.217 51 (60) 19 (48) 0.189
Diabetes mellitus, N (%) 101 (28) 1 (25) 0.911 18 (21) 9 (23) 0.867
Hyperlipidemia, N (%) 153 (42) 1 (25) 0.627 19 (22) 7 (18) 0.533
BMI (kg/m2), meanSD 284 273 0.798 274 295 0.163
Antiarrhythmic drugs, N (%) 0.929 0.032
Class I 2 (1) 0 0 0
Class II 251 (68) 3 (75) 54 (64) 21 (53)
Class III 5 (1) 0 17 (55) 5 (13)
Class IV 13 (4) 0 4 (5) 0
Left ventricular function, N (%) 0.303 0.604
Normal 279 (76) 3 (75) 58 (68) 24 (60)
Mild impairment 68 (19) 0 18 (21) 10 (25)
Moderate impairment 19 (5) 1 (25) 8 (9) 6 (15)
Severe impairment 1 (<1) 0 1 (1) 0
Left atrial dilatation, N (%) 64 (17) 2 (50) 0.090 37 (44) 28 (70) 0.002
AF type before CS, N (%) 0.260
Paroxysmal AF 34 (40) 20 (50)
Persistent AF 33 (39) 13 (33)
Long-standing Persistent AF 17 (20) 4 (10)
Permanent AF 1 (1) 2 (5)
Surgical ablation, N (%) 60 (71) 20 (50) 0.025
AF indicates atrial ﬁbrillation; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, congenital heart disease; CS, cardiac surgery; LPoAF, late postoperative atrial ﬁbrillation;
and VHS, valvular heart surgery.
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cause a higher vulnerability for development of AF.16 Previous
studies showed that, in patients in sinus rhythm, the extent of
this arrhythmogenic substrate is highly variable in patients
with similar clinical proﬁles.17–19 Hence, all these factors
might contribute to the lacking correlation between AF
inducibility alone and development of EPoAF.
Late Postoperative AF
The incidence of LPoAF in patients without AF before surgery
in our study was only 2%. Subsequently, correlations between
either AF inducibility or EPoAF and development of LPoAF
were absent. This is in contrast to other reports, in which
incidence of LPoAF was both higher and correlated to EPoAF.9
In a matched cohort of 488 patients without AF undergoing
off-pump CABG, development of LPoAF was evaluated during
a 4123 month follow-up period. LPoAF developed in 1.4% of
patients without EPoAF, compared with 10.2% of patients with
EPoAF (P<0.001). The difference in LPoAF prevalence is most
likely due to the longer follow-up period (up to 87 months) in
the latter study group.
In another cohort, consisting of 571 CABG patients, EPoAF
developed in 29%. Patients with EPoAF had an 8-fold increase in
the risk of LPoAF development during a 3-year follow-up
period.6 Ambrosetti8 followed 710 patients after CABG and/or
VHS. The overall LPoAF prevalence was 11% and was associ-
ated with development of EPoAF. However, it is unknown
whether patients had AF or other arrhythmias before surgery. In
the present study, the overall LPoAF incidence was 14% and is
thus comparable to the results provided by Ambrosetti.
Given the variances in prevalence of LPoAF and the low
prevalence in our cohort, the causative relation between
cardiothoracic surgery and LPoAF might be questionable.
Although one can advocate for the presence of such a relation if
LPoAF develops shortly after surgery, this becomes uncertain
when LPoAF develops more than several months after surgery.
By that time, surgery-associated triggers including, for example,
sterile inﬂammatory responses and oxidative stress are no
longer present. However, general risk factors for AF such as
decompensated heart failure and infections are more likely to
be responsible for triggering of LPoAF episodes.
Development of LPoAF recurrences after surgical ablation
in the present study was 25%. This is somewhat similar to
previous studies, reporting 66% to 69% success rates 1 year
after concomitant surgical ablation.20,21
Clinical Implications
EPoAF episodes in the current population are usually transient
and not predictive for LPoAF. Based on our ﬁndings, one could
argue whether long-term oral anticoagulants are indeed
mandatory, although included as a Class IIa indication in the
AF guidelines.10 A more conservative approach in this
subpopulation may be justiﬁed with the present data set.
In patients with AF before surgery in whom surgical
ablation for AF was performed, recurrence rates remain
relatively high. As a consequence, these patients should be
monitored closely for LPoAF recurrences, before discontinu-
ation of oral anticoagulants can even be considered.
Study Limitations
During long-term follow-up, LPoAF had to be documented on
ECGs or Holter recordings. Consequently, asymptomatic
short-lasting AF episodes could have been missed. For the
subanalysis regarding late postoperative AF we chose to
include only patients who completed the 2-year follow-up or
developed LPoAF within this period. Since a selection of
patients had not yet reached the 2-year end point, they were
not included for the subanalysis.
Conclusion
Intraoperative AF inducibility does not predict development of
either EPoAF or LPoAF. In patients with AF before surgery,
EPoAF is correlated with LPoAF recurrences. This correlation
is absent in patients without AF before surgery, in whom the
incidence of LPoAF is very low.
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